These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6796795)

  • 1. Fungal metabolism of (-)-deprenyl and pargyline.
    Coutts RT; Foster BC; Pasutto FM
    Life Sci; 1981 Nov; 29(19):1951-8. PubMed ID: 6796795
    [No Abstract]   [Full Text] [Related]  

  • 2. Deprenyl is metabolized to methamphetamine and amphetamine in man.
    Reynolds GP; Elsworth JD; Blau K; Sandler M; Lees AJ; Stern GM
    Br J Clin Pharmacol; 1978 Dec; 6(6):542-4. PubMed ID: 728327
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat: relationship of metabolism to MAO-B inhibitory potency.
    Yoshida T; Yamada Y; Yamamoto T; Kuroiwa Y
    Xenobiotica; 1986 Feb; 16(2):129-36. PubMed ID: 3083608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Phenylethylamine and amphetamine in human brain: effects of L-deprenyl in Parkinson's disease [proceedings].
    Reynolds GP; Riederer P; Sandler M
    Biochem Soc Trans; 1979 Feb; 7(1):143-5. PubMed ID: 437259
    [No Abstract]   [Full Text] [Related]  

  • 5. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine, p-hydroxyamphetamine and beta-phenethylamine in mouse brain and urine after (-)- and (+)-deprenyl administration.
    Philips SR
    J Pharm Pharmacol; 1981 Nov; 33(11):739-41. PubMed ID: 6118419
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.
    Karoum F; Chuang LW; Eisler T; Calne DB; Liebowitz MR; Quitkin FM; Klein DF; Wyatt RJ
    Neurology; 1982 May; 32(5):503-9. PubMed ID: 6803190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic and extrahepatic metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor, of amphetamines in rats: sex and strain differences.
    Yoshida T; Oguro T; Kuroiwa Y
    Xenobiotica; 1987 Aug; 17(8):957-63. PubMed ID: 3118583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Methyl-benzylamine, a metabolite of pargyline in man.
    Pirisino R; Ciottoli GB; Buffoni F; Anselmi B; Curradi C
    Br J Clin Pharmacol; 1979 Jun; 7(6):595-8. PubMed ID: 465282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation of aryl alkylamines by Cunninghamella bainieri.
    Foster BC; Coutts RT; Pasutto FM
    Xenobiotica; 1989 May; 19(5):531-8. PubMed ID: 2750209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatographic studies on the binding, action and metabolism of (-)-deprenyl.
    Kalász H; Kerecsen L; Knoll J; Pucsok J
    J Chromatogr; 1990 Jan; 499():589-99. PubMed ID: 2108980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic aspects of deprenyl effects.
    Magyar K; Tóthfalusi L
    Pol J Pharmacol Pharm; 1984; 36(4):373-84. PubMed ID: 6441926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolic activity of porcine FAD-containing monooxygenase by selective monoamine oxidase-B inhibitors.
    Wu RF; Ichikawa Y
    FEBS Lett; 1995 Jan; 358(2):145-8. PubMed ID: 7828725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the amine metabolites of selegiline in biological fluids by capillary gas chromatography.
    Salonen JS
    J Chromatogr; 1990 Apr; 527(1):163-8. PubMed ID: 2114418
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic transformation of deprenyl enantiomers in rats.
    Szökö E; Kalász H; Magyar K
    Neurobiology (Bp); 1999; 7(2):247-54. PubMed ID: 10591057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic transformation plays a primary role in the psychostimulant-like discriminative-stimulus effects of selegiline [(R)-(-)-deprenyl].
    Yasar S; Justinova Z; Lee SH; Stefanski R; Goldberg SR; Tanda G
    J Pharmacol Exp Ther; 2006 Apr; 317(1):387-94. PubMed ID: 16352699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and distribution of benzylamine in tissue extracts isolated from rats pretreated with pargyline.
    Durden DA; Philips ST; Boulton AA
    Biochem Pharmacol; 1976 Apr; 25(7):858-9. PubMed ID: 938586
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of the N-oxidation of deprenyl, methamphetamine, and amphetamine enantiomers by chiral capillary electrophoresis: an in vitro metabolism study.
    Szöko E; Tábi T; Borbás T; Dalmadi B; Tihanyi K; Magyar K
    Electrophoresis; 2004 Aug; 25(16):2866-75. PubMed ID: 15352021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective, irreversible in vivo binding of [11C]clorgyline and [11C]-L-deprenyl in mice: potential for measurement of functional monoamine oxidase activity in brain using positron emission tomography.
    MacGregor RR; Halldin C; Fowler JS; Wolf AP; Arnett CD; Langström B; Alexoff D
    Biochem Pharmacol; 1985 Sep; 34(17):3207-10. PubMed ID: 3929788
    [No Abstract]   [Full Text] [Related]  

  • 20. Clorgyline and deprenyl insensitive monoamine oxidase in rat brain soluble fraction.
    Shekhar C; Mayanil K; Baquer NZ
    Biochem Pharmacol; 1982 Dec; 31(23):3925-7. PubMed ID: 6818972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.